Vimovo (Horizon Pharma Inc.)
Welcome to the PulseAid listing for the Vimovo drug offered from Horizon Pharma Inc.. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Horizon Pharma Inc. |
| NON-PROPRIETARY NAME: | Naproxen and Esomeprazole Magnesium |
| SUBSTANCE NAME: | NAPROXEN; ESOMEPRAZOLE MAGNESIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-01-01 |
| END MARKETING DATE: | 0000-00-00 |
Vimovo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vimovo from Horizon Pharma Inc. |
| LABELER NAME: | Horizon Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2014-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 75987-030_01d394a4-2c7a-4aee-b741-807334538a30 |
| PRODUCT NDC: | 75987-030 |
| APPLICATION NUMBER: | NDA022511 |
Other NAPROXEN; ESOMEPRAZOLE MAGNESIUM Pharmaceutical Manufacturers / Labelers:
